García-Yuste Mariano, Matilla José M, Cueto Antonio, Paniagua José Manuel Rodríguez, Ramos Guillermo, Cañizares Miguel Angel, Muguruza Ignacio
Thoracic Surgery Department of University Hospital, Valladolid, Spain.
Eur J Cardiothorac Surg. 2007 Feb;31(2):192-7. doi: 10.1016/j.ejcts.2006.11.031. Epub 2006 Dec 29.
This study examines the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung with patients treated surgically for typical and atypical carcinoid tumours.
From 1980 to 2002, 661 patients were treated surgically for 569 typical carcinoid tumours and 92 atypical carcinoid tumours. Three hundred and four cases were studied retrospectively from 1980 to 1997 (261 typical carcinoid and 43 atypical carcinoid tumours); the other 357 new cases (308 typical carcinoid and 49 atypical carcinoid tumours) were collected prospectively from 1998 to 2002. Tumours were classified according the 1999 classification from the WHO and the International Association for the Study of Lung Cancer (IASLC). Several variables were reviewed in all patients. Univariate and multivariate statistical analyses were performed in order to determine whether clinical characteristics were associated with significant differences in survival.
In the total of the patients, 5-year survival for different tumours was as follows: typical carcinoid: overall survival 97%; with nodal involvement 100%; atypical carcinoid: overall 78%; with nodal involvement 60%. A significant difference in survival was found between patients in the retrospective and prospective groups with atypical carcinoid and nodal involvement. The comparative analysis of several factors in typical and atypical carcinoid tumours showed a significant difference for mean age, tumour size, nodal involvement and distant metastases.
Nodal involvement and histological sub-type appear as the most important factors influencing the prognosis. Adequate lung resection and systematic radical mediastinal lymphadenectomy should always be performed. Sleeve resection could be performed in central typical and atypical carcinoid tumours, avoiding pneumonectomy.
本研究探讨了西班牙多中心肺神经内分泌肿瘤研究中接受手术治疗的典型和非典型类癌患者的经历。
1980年至2002年期间,661例患者接受了手术治疗,其中569例为典型类癌肿瘤,92例为非典型类癌肿瘤。对1980年至1997年的304例病例进行回顾性研究(261例典型类癌和43例非典型类癌肿瘤);另外357例新病例(308例典型类癌和49例非典型类癌肿瘤)于1998年至2002年进行前瞻性收集。肿瘤根据世界卫生组织(WHO)和国际肺癌研究协会(IASLC)1999年的分类进行分类。对所有患者的多个变量进行了评估。进行单因素和多因素统计分析,以确定临床特征是否与生存的显著差异相关。
在所有患者中,不同肿瘤的5年生存率如下:典型类癌:总生存率97%;有淋巴结受累者为100%;非典型类癌:总体为78%;有淋巴结受累者为60%。在回顾性和前瞻性组中,非典型类癌且有淋巴结受累的患者之间存在显著的生存差异。典型和非典型类癌肿瘤的几个因素的比较分析显示,平均年龄、肿瘤大小、淋巴结受累和远处转移存在显著差异。
淋巴结受累和组织学亚型似乎是影响预后的最重要因素。应始终进行充分的肺切除和系统性纵隔淋巴结清扫术。对于中央型典型和非典型类癌肿瘤,可进行袖状切除术,避免全肺切除术。